REFERENCE
Takano H, Yamamoto E, Takano M, Takagi G, Asai K, Yasutake M, Mizuno K.Economical benefit of the prevention of contrast-induced nephropathy in patients with chronic kidney disease ESC Congress 2009: Annual Congress of the European Society of Cardiology: abstr. P1491, 29 Aug 2009. Available from: URL: http://www.escardio.org
Rights and permissions
About this article
Cite this article
The prevention of contrast-induced nephropathy by minimising the contrast agent “confers significant economical benefit”. Pharmacoecon. Outcomes News 588, 10 (2009). https://doi.org/10.2165/00151234-200905880-00026
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905880-00026